Alector, Inc. Common Stock

ALECNASDAQ • USD
1.99 USD
↗ 0.18 (9.83%)🟢LIVE (AS OF 03:51 PM EDT)
🟢Market: OPEN

Shares of Alector, Inc. Common Stock (ALEC) are trading at $1.99. Both sides of the analysis point lower: technicals flash "Strong Sell" and fundamentals confirm with a "Sell" reading. Notable factors include a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 2/9, exceptional Return on Equity (1184.8%) and a bullish Golden Cross on the moving averages. Valuation-wise, the stock is priced at a premium — multiples like P/E and EV/EBITDA sit above sector averages.

Technical & fundamental data as of Oct 2, 2026.

Open?$2.73
High?$3.21
Low?$1.82
Prev. Close?$1.81
Volume?87.1M
Avg. Volume?1.2M
VWAP?$2.55
Rel. Volume?70.06x
Bid / Ask
Bid?$1.99 × 3.2K
Ask?$2.00 × 4.2K
Spread?$0.01
Midpoint?$2.00
Valuation & Ratios
Market Cap?202.1M
Shares Out?111.7M
Float?92.3M
Float %?82.7%
P/E Ratio?N/A
P/B Ratio?-20.27
EPS?-$1.06
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Alector Inc is a clinical-stage biotechnology company focused on developing therapies for neurodegenerative diseases. The company advances a pipeline of product candidates including Nivisnebart (AL101/GSK4527226) for Alzheimer's disease, AL137 for Alzheimer's disease, AL050 for Parkinson's disease and Lewy body dementia, and AL064, an siRNA program targeting tau for Alzheimer's disease and other tauopathies, supported by its proprietary Alector Brain Carrier (ABC) platform designed to improve delivery of therapeutics across the blood-brain barrier.
Employees
103
Market Cap
202.1M
Industry
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Listed
2019-02-07
Address
131 OYSTER POINT BLVD., SUITE 600
SOUTH SAN FRANCISCO, CA 94080
Phone: 415-231-5660
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-2/3)
Medium-Term (Wave)?▼ Bearish(-3/3)
Short-Term (Ripple)?▲ Bullish(+1/3)
MA Alignment?Mixed
Full Technical Analysis →
Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?
12
Z-Score?
0
Momentum?
50
Short Sent.?
49
Piotroski F-Score?2/9Weak
Altman Z-Score?-7.58Distress
Confidence?58%Low
Full Fundamental Analysis →
Short InterestElevated
Short % of Float?6.62%Elevated
Short Interest?6.1M
Days to Cover?3.3
Free Float92.3M
Avg Daily Volume1.8M
Settlement Date2026-09-15
Financial Health
Current Ratio?5.26Strong
Quick Ratio?5.26Strong
Cash Ratio?1.75Strong
Debt/Equity?-0.99Low
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score
67/100
P/E?
N/A▾
P/B?
S&P
97
-20.27CHEAP▾
P/S?
Peers
100
S&P
3
14.58HIGH▾
P/FCF?
N/A▾
EV/EBITDA?
S&P
97
-1.3CHEAP▾
EV/Sales?
Peers
100
S&P
9
10.97HIGH▾
Returns & Efficiency
ROE?
Peers
50
S&P
97
1,184.8%STRONG▾
ROA?
S&P
3
-58.2%WEAK▾
Cash Flow & Enterprise
FCF?$-158392000
Enterprise Value?$152.0M
Fundamentals ratios updated end of day